The ClinImmune Cellular Therapy Laboratory owns the University of Colorado Cord Blood Bank and merged in 2018 with the St. Louis Cord Blood Bank. Both banks are licensed by the United States Food and Drug Administration (FDA).
The laboratory provides hematopoietic stem cell processing for the University of Colorado Hospital Bone Marrow Transplantation Program and is accredited by the Foundation for Accreditation of Cellular Therapy (FACT) and by the College of American Pathologists (CAP).
By combining the infrastructure for stem cell and cord blood processing, ClinImmune Labs achieves significant economies of scale that ensure cost-effective services for our clients.
The ClinImmune Cellular Therapy Laboratory supports a number of clinical cell therapy trials developed by outside companies.